Richard Giltner's most recent trade in United Therapeutics Corp was a trade of 1,310 Restricted Stock Unit done . Disclosure was reported to the exchange on July 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | Richard Giltner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2025 | 1,310 | 1,310 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2025 | 1,190 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2025 | 1,190 | 20,574 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2025 | 5,000 | 0 | - | - | Stock Option | |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 24 Jun 2025 | 5,000 | 22,420 (0%) | 0% | 175.4 | 877,150 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Sale of securities on an exchange or to another person at price $ 289.60 per share. | 24 Jun 2025 | 3,036 | 19,384 (0%) | 0% | 289.6 | 879,214 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 05 Nov 2024 | 10,000 | 27,420 (0%) | 0% | 175.4 | 1,754,300 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2024 | 10,000 | 5,000 | - | - | Stock Options | |
| United Therapeutics Corp | Richard Giltner | Director | Sale of securities on an exchange or to another person at price $ 381.61 per share. | 05 Nov 2024 | 8,571 | 18,849 (0%) | 0% | 381.6 | 3,270,749 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Sale of securities on an exchange or to another person at price $ 382.28 per share. | 05 Nov 2024 | 1,429 | 17,420 (0%) | 0% | 382.3 | 546,273 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 1,190 | 1,190 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2024 | 1,800 | 17,420 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2024 | 1,800 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Richard Giltner | Director | Sale or transfer of securities back to the company at price $ 236.97 per share. | 06 Mar 2024 | 10,000 | 15,620 (0%) | 0% | 237.0 | 2,369,700 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 10,000 | 0 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 06 Mar 2024 | 10,000 | 25,620 (0%) | 0% | 88.0 | 880,300 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 01 Dec 2023 | 5,000 | 20,620 (0%) | 0% | 88.0 | 440,150 | Common Stock |
| United Therapeutics Corp | Giltner Richard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 5,000 | 10,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Richard Giltner | Director | Sale or transfer of securities back to the company at price $ 240.73 per share. | 01 Dec 2023 | 5,000 | 15,620 (0%) | 0% | 240.7 | 1,203,650 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2023 | 1,800 | 1,800 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 1,750 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 1,750 | 15,620 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Richard Giltner | Director | Sale or transfer of securities back to the company at price $ 218.59 per share. | 22 May 2023 | 5,000 | 13,870 (0%) | 0% | 218.6 | 1,092,950 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2023 | 5,000 | 0 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 22 May 2023 | 5,000 | 18,870 (0%) | 0% | 63.9 | 319,500 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Sale or transfer of securities back to the company at price $ 261.05 per share. | 16 Nov 2022 | 10,000 | 13,870 (0%) | 0% | 261.1 | 2,610,500 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2022 | 10,000 | 5,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 16 Nov 2022 | 10,000 | 23,870 (0%) | 0% | 63.9 | 639,000 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 2,160 | 13,870 (0%) | 0% | 0 | Common | |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 2,160 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Richard Giltner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 1,750 | 1,750 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Richard Giltner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2021 | 2,160 | 2,160 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2021 | 3,360 | 11,710 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2021 | 3,360 | 0 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Richard Giltner | Director | Sale or transfer of securities back to the company at price $ 163.51 per share. | 06 Jan 2021 | 10,000 | 8,350 (0%) | 0% | 163.5 | 1,635,100 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 10,000 | 0 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.11 per share. | 06 Jan 2021 | 10,000 | 18,350 (0%) | 0% | 48.1 | 481,100 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.77 per share. | 04 Jan 2021 | 5,000 | 13,350 (0%) | 0% | 54.8 | 273,850 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 5,000 | 10,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Richard Giltner | Director | Sale or transfer of securities back to the company at price $ 156.77 per share. | 04 Jan 2021 | 5,000 | 8,350 (0%) | 0% | 156.8 | 783,850 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.11 per share. | 04 Jan 2021 | 5,000 | 13,350 (0%) | 0% | 48.1 | 240,550 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 5,000 | 0 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Richard Giltner | Director | Sale or transfer of securities back to the company at price $ 153.94 per share. | 04 Jan 2021 | 5,000 | 8,350 (0%) | 0% | 153.9 | 769,700 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2020 | 5,000 | 5,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Richard Giltner | Director | Sale or transfer of securities back to the company at price $ 148.44 per share. | 17 Dec 2020 | 5,000 | 8,350 (0%) | 0% | 148.4 | 742,200 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.77 per share. | 17 Dec 2020 | 5,000 | 13,350 (0%) | 0% | 54.8 | 273,850 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Sale or transfer of securities back to the company at price $ 139.47 per share. | 04 Nov 2020 | 5,000 | 8,350 (0%) | 0% | 139.5 | 697,350 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.77 per share. | 04 Nov 2020 | 5,000 | 13,350 (0%) | 0% | 54.8 | 273,850 | Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2020 | 5,000 | 10,000 | - | - | Share Tracking Award |